Literature DB >> 29453889

Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis.

Graham Campbell1, Don J Mahad1.   

Abstract

The neuron is the target of inflammatory demyelinating processes in multiple sclerosis (MS). In progressive MS, however, there is a gathering body of evidence indicating that molecular changes converge on mitochondria within neuronal cell bodies. The most reproducible change relates to mitochondrial respiratory chain complex deficiency, which compromises the capacity of neurons to generate ATP. The resulting energy failure state is coupled with an increase in demand for energy by the demyelinated axon, being particularly relevant to the long tracts such as corticospinal tracts with long projection axons. Recent work in our laboratory and that of our collaborators indicates the limited reflection of the mitochondria changes within neurons in experimental disease models. The mitochondrial changes within neuronal compartments are likely to offer novel targets for the improvement in neuronal function in patients with progressive MS.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  demyelination; mitochondria; multiple sclerosis; neurodegeneration; progression

Mesh:

Substances:

Year:  2018        PMID: 29453889     DOI: 10.1002/1873-3468.13013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  Interactions between mitochondria and endoplasmic reticulum in demyelinated axons.

Authors:  Truc Quynh Thai; Huy Bang Nguyen; Yang Sui; Kazuhiro Ikenaka; Toshiyuki Oda; Nobuhiko Ohno
Journal:  Med Mol Morphol       Date:  2018-11-17       Impact factor: 2.309

Review 2.  Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis.

Authors:  Heather Y F Yong; V Wee Yong
Journal:  Nat Rev Neurol       Date:  2021-11-03       Impact factor: 42.937

Review 3.  Melatonin and Multiple Sclerosis: From Plausible Neuropharmacological Mechanisms of Action to Experimental and Clinical Evidence.

Authors:  Mahshid Yeganeh Salehpour; Adriano Mollica; Saeideh Momtaz; Nima Sanadgol; Mohammad Hosein Farzaei
Journal:  Clin Drug Investig       Date:  2019-07       Impact factor: 2.859

4.  Nrf2 Signaling in Sodium Azide-Treated Oligodendrocytes Restores Mitochondrial Functions.

Authors:  Annette Liessem-Schmitz; Nico Teske; Miriam Scheld; Stella Nyamoya; Adib Zendedel; Cordian Beyer; Tim Clarner; Athanassios Fragoulis
Journal:  J Mol Neurosci       Date:  2018-08-23       Impact factor: 3.444

5.  The m.11778 A > G variant associated with the coexistence of Leber's hereditary optic neuropathy and multiple sclerosis-like illness dysregulates the metabolic interplay between mitochondrial oxidative phosphorylation and glycolysis.

Authors:  Martine Uittenbogaard; Christine A Brantner; ZiShui Fang; Lee-Jun Wong; Andrea Gropman; Anne Chiaramello
Journal:  Mitochondrion       Date:  2018-06-08       Impact factor: 4.160

Review 6.  The Axon-Myelin Unit in Development and Degenerative Disease.

Authors:  Ruth M Stassart; Wiebke Möbius; Klaus-Armin Nave; Julia M Edgar
Journal:  Front Neurosci       Date:  2018-07-11       Impact factor: 4.677

7.  Variants of Mitochondrial Genome and Risk of Multiple Sclerosis Development in Russians.

Authors:  M S Kozin; O G Kulakova; I S Kiselev; O P Balanovsky; A N Boyko; O O Favorova
Journal:  Acta Naturae       Date:  2018 Oct-Dec       Impact factor: 1.845

8.  In vivo real-time dynamics of ATP and ROS production in axonal mitochondria show decoupling in mouse models of peripheral neuropathies.

Authors:  Gerben van Hameren; Graham Campbell; Marie Deck; Jade Berthelot; Benoit Gautier; Patrice Quintana; Roman Chrast; Nicolas Tricaud
Journal:  Acta Neuropathol Commun       Date:  2019-06-11       Impact factor: 7.801

9.  Gray matter blood-brain barrier water exchange dynamics are reduced in progressive multiple sclerosis.

Authors:  Ian J Tagge; Valerie C Anderson; Charles S Springer; Manoj K Sammi; Dennis N Bourdette; Rebecca I Spain; William D Rooney
Journal:  J Neuroimaging       Date:  2021-08-06       Impact factor: 2.324

Review 10.  On the Neuroprotective Role of Astaxanthin: New Perspectives?

Authors:  Christian Galasso; Ida Orefice; Paola Pellone; Paola Cirino; Roberta Miele; Adrianna Ianora; Christophe Brunet; Clementina Sansone
Journal:  Mar Drugs       Date:  2018-07-24       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.